x

References: Prevention and health promotion

last modified: 19/10/2010 11:53

The following are the references that support chapter 3 (back to chapter 3).

Feel free to review them and to suggest improvements by clicking on the green bubble marked 'Comments' that appears on the right top corner of each section.

1. Bonita R, Beaglehole R, Kjellstrom T. Basic Epidemiology. 2ªed. Geneva: WHO; 2006.
2. Research Australia. Healthy planet, places, and people. Canberra: Research Australia; 2007.
3. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the socail determinants of health. Geneva: WHO; 2008.
4. WHO. WHO report on the global tobacco epidemic, 2008. The MPOWER package. Geneva: WHO; 2008.
5. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146. DOI: 10.1002/14651858.CD000146.pub3
6. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008; 34(2): 102-111.
7. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007; 97(8): 1503-1509.
8. Saffer H. Tobacco advertising and promotion. In: Jha P, Chaloupka FI, eds. Tobacco control in developing countries. Oxford: Oxford University Press; 2000.
9. Van Walbeek C. Tobacco excise in South Africa: tools for advancing tobacco control in the XX1st century: success stories and lessons learned. Geneva: WHO; 2003.
10.World Health Organisation. Preventing chronic diseases: a vital investment. Geneva: WHO; 2005.
11. Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006; (4): CD003817. DOI: 10.1002/14651858.CD003817.pub3
12. Hagobian TA, Braun B. Physical Activity and Hormonal Regulation of Appetite: Sex Differences and Weigth Control. Exerc Sport Sci Rev. 2010; 38(1):25-30.
13.Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004 Sep; 12(9):1426-34.
14. Rejeski WJ, Mihalko SL. Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci. (2001); 56(Suppl 2):23-35. DOI:10.1093/gerona/56.suppl_2.23
15. WHO. Interventions on diet and physical activity: what works. Geneva: WHO; 2009.
16. Glazier, RH, Booth GL, Gozdyra P, Creatore M, Tynan, A. Neighbourhood environments and resources for health living – a focus on diabetes in Toronto. Toronto: Institute for Clinical Evaluative Sciences; 2007.
17. WHO. Prevention of cardiovascular disease. Geneva: WHO; 2007.
18. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335(7611):136.
19. Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for predicting cardiovascular risk? BMJ. 2009; 339:b2673.
20. National Institute of Health and Clinical excellence (NICE). MI: secondary prevention. Statins for the prevention of cardiovascular events. London: NICE; 2006.
21. Pearson TA et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002; 106(3):388-391.
22. Antithrombotic Triallists Collaboration et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30; 373(9678):1849-60.
23. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326(7404): 1419-23.
24. Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009 Apr 18; 373(9672):1341-51.
25. Mendis S, Abegunde D, Yusuf S, Ebrahim S, Shaper G, Ghannem H, Shengelia B. WHO study on prevention and recurrence of myocardial infraction and stroke (WHO-PREMISE). Bull World Health Organ. 2005; 83(11): 820-8.
26. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587. DOI: 10.1136/bmj.b2587
27. MedicineNet.com. [Web site]. [Access date April 1st, 2010]. Definition of QALY. Available at: http://www.medterms.com/script/main/art.asp?articlekey=7924
28. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003; 326(7395): 901. DOI:10.1136/bmj.326.7395.901
29. Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59.

Are you sure you want to delete this section?References: Prevention and health promotion: 1. Bonita R, Beaglehole R, Kjellstrom T. Basic Epidemiology. 2ªed. ...

8 votes

x

References: Prevention and health promotion

Table of contents

1. Bonita R, Beaglehole R, Kjellstrom T. Basic Epidemiology. 2ªed. Geneva: WHO; 2006.

2. Research Australia. Healthy planet, places, and people. Canberra: Research Australia; 2007.

3. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the socail determinants of health. Geneva: WHO; 2008.

4. WHO. WHO report on the global tobacco epidemic, 2008. The MPOWER package. Geneva: WHO; 2008.

5. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146. DOI: 10.1002/14651858.CD000146.pub3

6. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008; 34(2): 102-111.

7. Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007; 97(8): 1503-1509.

8. Saffer H. Tobacco advertising and promotion. In: Jha P, Chaloupka FI, eds. Tobacco control in developing countries. Oxford: Oxford University Press; 2000.

9. Van Walbeek C. Tobacco excise in South Africa: tools for advancing tobacco control in the XX1st century: success stories and lessons learned. Geneva: WHO; 2003.

10.World Health Organisation. Preventing chronic diseases: a vital investment. Geneva: WHO; 2005.

11. Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006; (4): CD003817. DOI: 10.1002/14651858.CD003817.pub3

12. Hagobian TA, Braun B. Physical Activity and Hormonal Regulation of Appetite: Sex Differences and Weigth Control. Exerc Sport Sci Rev. 2010; 38(1):25-30.

13.Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004 Sep; 12(9):1426-34.

14. Rejeski WJ, Mihalko SL. Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci. (2001); 56(Suppl 2):23-35. DOI:10.1093/gerona/56.suppl_2.23

15. WHO. Interventions on diet and physical activity: what works. Geneva: WHO; 2009.

16. Glazier, RH, Booth GL, Gozdyra P, Creatore M, Tynan, A. Neighbourhood environments and resources for health living – a focus on diabetes in Toronto. Toronto: Institute for Clinical Evaluative Sciences; 2007.

17. WHO. Prevention of cardiovascular disease. Geneva: WHO; 2007.

18. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335(7611):136.

19. Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for predicting cardiovascular risk? BMJ. 2009; 339:b2673.

20. National Institute of Health and Clinical excellence (NICE). MI: secondary prevention. Statins for the prevention of cardiovascular events. London: NICE; 2006.

22. Antithrombotic Triallists Collaboration et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30; 373(9678):1849-60.

23. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326(7404): 1419-23.

25. Mendis S, Abegunde D, Yusuf S, Ebrahim S, Shaper G, Ghannem H, Shengelia B. WHO study on prevention and recurrence of myocardial infraction and stroke (WHO-PREMISE). Bull World Health Organ. 2005; 83(11): 820-8.

26. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587. DOI: 10.1136/bmj.b2587

27. MedicineNet.com. [Web site]. [Access date April 1st, 2010]. Definition of QALY. Available at: http://www.medterms.com/script/main/art.asp?articlekey=7924

28. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003; 326(7395): 901. DOI:10.1136/bmj.326.7395.901

29. Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59.

Comments to the whole document

OPIMEC

Social media

Subscriptions

27. MedicineNet.com. [Web site]. [Access date April 1^st, 2010]. Definition of QALY. Available at: http://www.medterms.com/script/main/art.asp?articlekey=7924